News Items

News Items

Share this post

News Items
News Items
Two Baby Girls.
Copy link
Facebook
Email
Notes
More

Two Baby Girls.

Where the modern world was born.

John Ellis
Apr 25, 2023
∙ Paid
11

Share this post

News Items
News Items
Two Baby Girls.
Copy link
Facebook
Email
Notes
More
2
Share

Get 14 day free trial


1. An exciting new genetic therapy for Alzheimer’s disease is safe and successfully lowered levels of the harmful tau protein known to cause the disease, in a world first trial at UCLH and UCL. The trial, led by consultant neurologist Dr Catherine Mummery at the National Hospital for Neurology and Neurosurgery, represents the first time that a ‘gene silencing’ approach has been taken in dementia and in AD. In this approach, the aim is to use a drug to ‘silence’ the gene coding for the tau protein – the microtubule-associated protein tau (MAPT) gene – with a drug called BIIB080, which is an antisense oligonucleotide. This prevents the gene being translated into the protein in a dose-able, reversible way. This can then lower the production of that protein and alter the course of disease. Further trials will be needed in larger groups of patients to determine whether this then leads to clinical benefit, but the phase 1 results published today in Nature Medicine are the first indication that this method has a biological effect. (Sources: uclh.nhs.uk, rcp.ac.uk, nature.com)

Keep reading with a 7-day free trial

Subscribe to News Items to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 John Ellis
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More